CFD merupakan instrumen yang rumit dan memiliki risiko tinggi kehilangan uang secara cepat karena adanya pengaruh leverage. 84% akun investor ritel mengalami kerugian saat melakukan kegiatan perdagangan CFD dengan penyedia ini. Anda harus mempertimbangkan apakah Anda memahami cara kerja CFD dan apakah Anda mampu menerima risiko tinggi kehilangan uang.

Scan to Download iOS&Android APP

Perdagangan AstraZeneca PLC - GBP - AZNl CFD

107.99
0.09%
0.24
Rendah: 106.43
Tinggi: 107.89
Market Trading Hours* (UTC) Open now
Closes on Monday at 16:30

Mon - Fri: 08:00 - 12:00 12:03 - 16:30

  • Summary
  • Historical Data
  • Events
  • Income Statement
  • Balance Sheet
  • Cash Flow
  • Ownership
Trading Conditions
Spread 0.24
Biaya inap posisi Long

Long position overnight fee


Margin. Your investment $1,000.00
Biaya Overnight -0.021808 %
Charges from borrowed part ($-0.87)
Trade size with leverage ~ $5,000.00
Money from leverage ~ $4,000.00

Kunjungi platform
-0.021808%
Biaya inap posisi short

Short position overnight fee


Margin. Your investment $1,000.00
Biaya Overnight -0.00011 %
Charges from borrowed part ($-0.00)
Trade size with leverage ~ $5,000.00
Money from leverage ~ $4,000.00

Kunjungi platform
-0.00011%
Waktu biaya inap 21:00 (UTC)
Kuantitas min. yang diperdagangkan 1
Mata uang GBP
Margin 20%
Bursa efek United Kingdom of Great Britain and Northern Ireland
Komisi perdagangan 0%

*Information provided by Capital.com

AstraZeneca PLC ESG Risk Ratings

High Medium Low Negligible

‘C’ score indicates satisfactory relative ESG performance and moderate degree of transparency in reporting material ESG data publicly.

Key Stats
Prev. Close* 107.77
Open* 107.73
1-Year Change* 12.94%
Day's Range* 106.43 - 107.89
52 wk Range 93.99-128.29
Average Volume (10 days) 2.32M
Average Volume (3 months) 41.08M
Market Cap 166.66B
P/E Ratio 62.12
Shares Outstanding 1.55B
Revenue 36.43B
EPS 1.73
Dividend (Yield %) 2.21195
Beta 0.28
Next Earnings Date Apr 27, 2023

All data is provided by Refinitiv, except for data marked with an asterisk, which is *data provided by Capital.com

  • Last Week
  • Last Month
  • Last Year
  • Last two Years
  • Max
  • Daily
  • Weekly
  • Monthly
Date Close Change Change (%) Open High Low
Mar 17, 2023 107.67 0.06 0.06% 107.61 109.11 107.29
Mar 16, 2023 107.87 2.10 1.99% 105.77 108.15 105.77
Mar 15, 2023 106.29 -0.60 -0.56% 106.89 107.85 106.19
Mar 14, 2023 106.47 0.22 0.21% 106.25 107.17 105.51
Mar 13, 2023 106.69 -0.18 -0.17% 106.87 108.47 105.43
Mar 10, 2023 106.63 -0.74 -0.69% 107.37 108.49 105.77
Mar 9, 2023 108.53 0.78 0.72% 107.75 109.33 107.69
Mar 8, 2023 107.95 -0.36 -0.33% 108.31 108.89 107.75
Mar 7, 2023 108.29 2.40 2.27% 105.89 108.93 105.89
Mar 6, 2023 107.33 -0.06 -0.06% 107.39 108.05 106.99
Mar 3, 2023 107.93 0.06 0.06% 107.87 108.73 107.71
Mar 2, 2023 108.35 1.22 1.14% 107.13 108.45 107.13
Mar 1, 2023 107.85 1.20 1.13% 106.65 108.83 106.65
Feb 28, 2023 108.53 -1.45 -1.32% 109.98 110.98 108.13
Feb 27, 2023 110.70 1.20 1.10% 109.50 111.50 109.50
Feb 24, 2023 110.84 -0.24 -0.22% 111.08 112.28 110.82
Feb 23, 2023 112.32 -2.48 -2.16% 114.80 114.80 111.56
Feb 22, 2023 114.74 0.02 0.02% 114.72 115.88 114.26
Feb 21, 2023 115.52 0.50 0.43% 115.02 116.66 115.02
Feb 20, 2023 115.08 0.30 0.26% 114.78 115.52 114.42

AstraZeneca PLC - GBP Events

Time (UTC) Country Event
No events scheduled
View all events
  • Annual
  • Quarterly
2016 2017 2018 2019 2020 2021
Total revenue 23002 22465 22090 24384 26617 37417
Revenue 23002 22465 22090 24384 26617 37417
Cost of Revenue, Total 4044 4180 4246 4824 5270 9542
Gross Profit 18958 18285 17844 19560 21347 27875
Total Operating Expense 18100 18788 18703 21460 21455 36361
Selling/General/Admin. Expenses, Total 8052 7650 8479 8964 9338 11519
Research & Development 5664 5412 5266 5320 6094 8519
Depreciation / Amortization 1529 1637 1945 1812 1897 3044
Unusual Expense (Income) -802 320 -953 863 -763 3846
Other Operating Expenses, Total -387 -250 -280 -323 -381 -109
Operating Income 4902 3677 3387 2924 5162 1056
Interest Income (Expense), Net Non-Operating -616 -764 -775 -766 -716 -819
Other, Net -734 -686 -619 -610 -530 -502
Net Income Before Taxes 3552 2227 1993 1548 3916 -265
Net Income After Taxes 3406 2252 2050 1227 3144 115
Minority Interest 93 133 105 108 52 -3
Net Income Before Extra. Items 3499 2385 2155 1335 3196 112
Net Income 3499 3001 2155 1335 3196 112
Income Available to Common Excl. Extra. Items 3499 2385 2155 1335 3196 112
Income Available to Common Incl. Extra. Items 3499 3001 2155 1335 3196 112
Dilution Adjustment 0 0 0
Diluted Net Income 3499 3001 2155 1335 3196 112
Diluted Weighted Average Shares 1266 1267 1267 1301 1313 1427
Diluted EPS Excluding Extraordinary Items 2.76382 1.8824 1.70087 1.02613 2.43412 0.07849
Dividends per Share - Common Stock Primary Issue 2.70034 2.73619 2.74532 2.89446 2.83031 2.84245
Diluted Normalized EPS 2.5237 1.36938 0.85399 1.48501 1.88804 2.22705
Interest Expense (Income) - Net Operating -161 0 0
Total Extraordinary Items 616
Q1 2021 Q2 2021 Q3 2021 Q4 2021 Q1 2022
Total revenue 7320 8220 9866 12011 11390
Revenue 7320 8220 9866 12011 11390
Cost of Revenue, Total 1920 2193 3824 3069 2279
Gross Profit 5400 6027 6042 8942 9111
Total Operating Expense 5425 7093 11540 12303 10512
Selling/General/Admin. Expenses, Total 2498 2574 2986 4082 3057
Research & Development 1638 1801 2153 2927 2186
Depreciation / Amortization 384 385 1209 1066 1098
Unusual Expense (Income) -920 269 1405 1007 2025
Other Operating Expenses, Total -95 -129 -37 152 -133
Operating Income 1895 1127 -1674 -292 878
Interest Income (Expense), Net Non-Operating -287 -363 -327 -344 -325
Net Income Before Taxes 1608 764 -2001 -636 553
Net Income After Taxes 1562 550 -1651 -346 388
Minority Interest -1 0 -1 -1 -2
Net Income Before Extra. Items 1561 550 -1652 -347 386
Net Income 1561 550 -1652 -347 386
Income Available to Common Excl. Extra. Items 1561 550 -1652 -347 386
Income Available to Common Incl. Extra. Items 1561 550 -1652 -347 386
Dilution Adjustment 0
Diluted Net Income 1561 550 -1652 -347 386
Diluted Weighted Average Shares 1319 1318 1496 1550 1561
Diluted EPS Excluding Extraordinary Items 1.18347 0.4173 -1.10428 -0.22387 0.24728
Dividends per Share - Common Stock Primary Issue 0 0.89599 0 1.96577 0
Diluted Normalized EPS 0.49507 0.5736 0.13971 1.00645 1.33953
  • Annual
  • Quarterly
2016 2017 2018 2019 2020 2021
Total Current Assets 13262 13150 15591 15563 19544 26244
Cash and Short Term Investments 5902 4554 5680 6218 7992 6398
Cash 782 784 893 755 1182 1461
Cash & Equivalents 4236 2540 3938 4614 6650 4868
Short Term Investments 884 1230 849 849 160 69
Total Receivables, Net 4001 4275 4345 5181 5651 8795
Accounts Receivable - Trade, Net 2583 2802 2995 3813 3956 6324
Total Inventory 2334 3035 2890 3193 4024 8983
Prepaid Expenses 998 1258 1436 865 1735 1512
Other Current Assets, Total 27 28 1240 106 142 556
Total Assets 62526 63354 60651 61377 66729 105363
Property/Plant/Equipment, Total - Net 6848 7615 7421 8335 8917 10171
Property/Plant/Equipment, Total - Gross 13451 14639 14639 15852 17110 18495
Accumulated Depreciation, Total -6603 -7024 -7218 -7517 -8193 -8324
Goodwill, Net 11658 11825 11707 11668 11845 19997
Intangibles, Net 27586 26188 21959 20833 20947 42387
Long Term Investments 826 1036 922 1459 1147 1237
Note Receivable - Long Term 901 847 515 348 325 504
Other Long Term Assets, Total 1445 2693 2536 3171 4004 4823
Total Current Liabilities 15256 16383 16292 18117 20307 22594
Accounts Payable 2990 3611 1720 1774 2350 2824
Accrued Expenses 3095 3794 5148 5085 4994 8079
Notes Payable/Short Term Debt 94 152 160 154 370 294
Current Port. of LT Debt/Capital Leases 2213 2095 1594 1856 2016 1599
Other Current Liabilities, Total 6864 6731 7670 9248 10577 9798
Total Liabilities 47672 48394 48183 48250 51107 66095
Total Long Term Debt 14501 15560 17359 16217 17994 28888
Long Term Debt 14495 15560 17359 15730 17505 28134
Capital Lease Obligations 6 0 0 487 489 754
Deferred Income Tax 3956 3995 3286 2490 2918 6206
Minority Interest 1815 1682 1576 1469 16 19
Other Liabilities, Total 12144 10774 9670 9957 9872 8388
Total Equity 14854 14960 12468 13127 15622 39268
Common Stock 316 317 317 328 328 387
Additional Paid-In Capital 4351 4393 4427 7941 7971 35126
Retained Earnings (Accumulated Deficit) 10187 10250 7724 4858 7323 3755
Total Liabilities & Shareholders’ Equity 62526 63354 60651 61377 66729 105363
Total Common Shares Outstanding 1265.23 1266.22 1267.04 1312.14 1312.67 1549.4
Mar 2021 Jun 2021 Sep 2021 Dec 2021 Mar 2022
Total Current Assets 18735 27274 26691 26244 22647
Cash and Short Term Investments 7765 15629 7149 6398 5823
Cash & Equivalents 7636 15567 7067 6329 5762
Short Term Investments 129 62 82 69 61
Total Receivables, Net 6628 6842 8854 10307 9050
Accounts Receivable - Trade, Net 6281 6356 8258 9644 8683
Total Inventory 4278 4762 10528 8983 7624
Other Current Assets, Total 64 41 160 556 150
Total Assets 64926 73641 107221 105363 100273
Property/Plant/Equipment, Total - Net 8849 9031 10162 10171 10015
Goodwill, Net 11765 11798 20081 19997 19963
Intangibles, Net 20347 20006 44104 42387 41265
Long Term Investments 1060 1120 1585 1237 1237
Note Receivable - Long Term 549 565 811 895 864
Other Long Term Assets, Total 3621 3847 3787 4432 4282
Total Current Liabilities 21513 22222 23649 22594 22740
Payable/Accrued 17370 17729 18663 18938 17864
Notes Payable/Short Term Debt 407 392 500 294 724
Current Port. of LT Debt/Capital Leases 1851 2502 2473 1599 1570
Other Current Liabilities, Total 1885 1599 2013 1763 2582
Total Liabilities 50496 57965 67477 66095 63933
Total Long Term Debt 17874 24601 28939 28888 28805
Long Term Debt 17410 24109 28206 28134 28081
Capital Lease Obligations 464 492 733 754 724
Deferred Income Tax 2823 2927 6400 6206 5626
Minority Interest 16 17 168 19 19
Other Liabilities, Total 8270 8198 8321 8388 6743
Total Equity 14430 15676 39744 39268 36340
Common Stock 328 328 387 387 387
Additional Paid-In Capital 7976 7980 35118 35126 35131
Retained Earnings (Accumulated Deficit) 6126 7368 4239 3755 822
Total Liabilities & Shareholders’ Equity 64926 73641 107221 105363 100273
Total Common Shares Outstanding 1312.74 1312.79 1549.14 1549.4 1549.45
  • Annual
  • Quarterly
2016 2017 2018 2019 2020 2021
Net income/Starting Line 3552 2227 1993 1548 3916 -265
Cash From Operating Activities 4145 3578 2618 2969 4799 5963
Cash From Operating Activities 2357 3036 3753 3762 3149 6530
Non-Cash Items -1601 -483 -1276 -103 -332 141
Cash Taxes Paid 412 454 537 1118 1562 1743
Cash Interest Paid 677 698 676 774 733 721
Changes in Working Capital -163 -1202 -1852 -2238 -1934 -443
Cash From Investing Activities -3969 -2328 963 -657 -285 -11058
Capital Expenditures -2314 -1620 -1371 -2460 -2606 -2200
Other Investing Cash Flow Items, Total -1655 -708 2334 1803 2321 -8858
Cash From Financing Activities -1324 -2936 -2044 -1765 -2203 3649
Financing Cash Flow Items 18 -20 -67 4 -101 -178
Total Cash Dividends Paid -3561 -3519 -3484 -3592 -3572 -3856
Issuance (Retirement) of Stock, Net 47 43 34 3525 30 29
Issuance (Retirement) of Debt, Net 2172 560 1473 -1702 1440 7654
Foreign Exchange Effects 21 -66 -38 5 12 -62
Net Change in Cash -1127 -1752 1499 552 2323 -1508
Mar 2021 Jun 2021 Sep 2021 Dec 2021 Mar 2022
Net income/Starting Line 1608 2372 371 -265 553
Cash From Operating Activities 1934 2826 4545 5963 3232
Cash From Operating Activities 797 1550 4338 6530 1309
Non-Cash Items -1162 -761 -507 141 -12
Cash Taxes Paid 332 869 1198 1743 228
Cash Interest Paid 187 323 522 721 194
Changes in Working Capital 691 -335 343 -443 1382
Cash From Investing Activities 555 319 -10145 -11058 -168
Capital Expenditures -469 -822 -1482 -2200 -363
Other Investing Cash Flow Items, Total 1024 1141 -8663 -8858 195
Cash From Financing Activities -2731 4558 4700 3649 -3740
Financing Cash Flow Items -23 -22 -28 -178 -997
Total Cash Dividends Paid -2469 -2469 -3856 -3856 -2971
Issuance (Retirement) of Stock, Net 5 9 10 29 5
Issuance (Retirement) of Debt, Net -244 7040 8574 7654 223
Foreign Exchange Effects -67 -52 -73 -62 -9
Net Change in Cash -309 7651 -973 -1508 -685
Investor Name Investor Type Percent Outstanding Shares Held Shares change Holdings Date Turnover Rating
BlackRock Institutional Trust Company, N.A. Investment Advisor 6.5099 100893184 1200 2023-01-31 LOW
Wellington Management Company, LLP Investment Advisor/Hedge Fund 4.2 65092368 768 2023-01-31 LOW
Capital Research Global Investors Investment Advisor 4.12 63852512 752 2023-01-31 LOW
Investor AB Private Equity 3.33 51608948 608 2023-01-31 LOW
The Vanguard Group, Inc. Investment Advisor/Hedge Fund 2.8464 44114976 -1215991 2022-12-14 LOW
Capital World Investors Investment Advisor 1.7648 27351981 2675871 2022-12-14 LOW
BlackRock Advisors (UK) Limited Investment Advisor/Hedge Fund 1.1934 18495433 289630 2023-03-01 LOW
BlackRock Investment Management (UK) Ltd. Investment Advisor/Hedge Fund 1.1402 17670785 0 2023-03-01 LOW
GQG Partners, LLC Investment Advisor 1.0697 16579162 1036509 2022-12-14 MED
State Street Global Advisors (UK) Ltd. Investment Advisor/Hedge Fund 0.6303 9768142 18173 2023-03-01 LOW
Nuveen LLC Pension Fund 0.6158 9543355 495683 2022-12-14 LOW
Geode Capital Management, L.L.C. Investment Advisor/Hedge Fund 0.5411 8386244 -95567 2022-12-14 LOW
Legal & General Investment Management Ltd. Investment Advisor/Hedge Fund 0.5082 7875720 214842 2022-12-14 LOW
State Street Global Advisors (US) Investment Advisor/Hedge Fund 0.5022 7783223 -7029 2023-03-01 LOW
Aviva Investors Global Services Limited Investment Advisor/Hedge Fund 0.5003 7754095 612331 2023-03-01 LOW
Fidelity Management & Research Company LLC Investment Advisor 0.4726 7325050 98350 2023-03-01 LOW
Handelsbanken Kapitalförvaltning AB Investment Advisor/Hedge Fund 0.47 7284582 919455 2023-02-28 LOW
Union Investment Privatfonds GmbH Investment Advisor 0.3731 5782579 -203480 2022-12-31 LOW
Royal London Asset Management Ltd. Investment Advisor/Hedge Fund 0.3705 5741791 5792 2023-03-01 MED
Schroder Investment Management Ltd. (SIM) Investment Advisor/Hedge Fund 0.3701 5735207 34985 2023-03-01 LOW

Mengapa memilih Capital.com? Biarlah angka kami yang berbicara.

Capital.com Group
500000+

Trader

92000+

Klien aktif per bulan

$53000000+

Volume investasi per bulan

$30000000+

Penarikan tiap bulan

Trading calculator

Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).

Trade commission
0
  • 1:1
Leverage
1:1
  • 20
  • 100
  • 500
  • 1000
  • 10000
Investment
Trade size (Leverage x Investement):
Open

Close

Short Long
Industry: Pharmaceuticals (NEC)

1 Francis Crick Avenue
CAMBRIDGE
CAMBRIDGESHIRE CB2 0AA
GB

Income Statement

  • Annual
  • Quarterly

People also watch

Oil - Crude

66.64 Price
+0.200% 1D Chg, %
Biaya inap posisi Long -0.0200%
Biaya inap posisi short -0.0019%
Waktu biaya inap 21:00 (UTC)
Spread 0.03

US100

12,547.10 Price
+0.240% 1D Chg, %
Biaya inap posisi Long -0.0241%
Biaya inap posisi short 0.0018%
Waktu biaya inap 21:00 (UTC)
Spread 1.8

BTC/USD

27,983.90 Price
+0.020% 1D Chg, %
Biaya inap posisi Long -0.0616%
Biaya inap posisi short 0.0137%
Waktu biaya inap 21:00 (UTC)
Spread 60.00

XRP/USD

0.38 Price
-1.810% 1D Chg, %
Biaya inap posisi Long -0.0753%
Biaya inap posisi short 0.0069%
Waktu biaya inap 21:00 (UTC)
Spread 0.00328

Masih mencari broker yang bisa Anda percayai?

Bergabung dengan 500.000+ trader di seluruh dunia yang telah memilih trading bersama Capital.com

1. Buat & verifikasi akun Anda 2. Lakukan deposit 3. Temukan trading Anda